CD8A and melanoma: Using the NTAmer technology, we also successfully measured the monomeric TCR–pMHC dissociation rates of a large series of natural A2/NY-ESO-1157–165- and Melan-AMART-126–35-specific CD8 T cell clones (n = 139) derived from various melanoma patients (42).